MORE►
National Institutes of Health
Abhimanyu Garg M.D. is director of metabolic diseases in the Center for Human Nutrition at UTSW. [Source photo: UTSW]
UTSW Researchers Find Autoantibody Linked to Rare Disorder That Destroys Fat
by Lance Murray | Feb 21, 2023
The UT Southwestern researchers discovered the first molecular biomarker for AGL, a rare disorder in which fat deposits are destroyed, causing patients to have dangerously low body fat, signs of accelerated aging, and severe metabolic diseases including diabetes and fatty liver.
by David Seeley |
Jan 26, 2023
Last month, we told you about MedCognetics getting FDA clearance for its unbiased AI-enabled software for breast cancer screening. Today, the Dallas-based company announced it has been awarded $750,000 from an NIH program to research unbiased AI for breast cancer detection.
The NIH's AIM-AHEAD program—short for Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Researcher Diversity—awarded the grant. "This NIH grant will play an important role in future product development as well as helping us further expand our global market penetration," said MedCognetics CEO Debasish Nag.
MORE►
by Lance Murray |
Dec 21, 2022
UT Southwestern researchers have used gene editing technology to develop what could be a breakthrough for dilated cardiomyopathy, a heart condition that affects one in 250 people worldwide.
“The pace of this field is really breathtaking,” said Eric Olson, Ph.D., who co-led the study. “I expect that if this moves forward into patients, we’re not talking within decades—we’re talking within years.”
MORE►
by Lance Murray |
Nov 9, 2022
The Perot family’s support will expand the number of students admitted to UT Southwestern's dual-degree program as well as research disciplines in which they study, to include biomedical engineering, computational biology, bioinformatics, and data science.
The funding will enhance the curriculum and experiences of Medical Scientist Training Program students and increase efforts to recruit students from elite U.S. colleges, including top international students who want to stay in the U.S. for their careers.
MORE►
[Illustration: ImagePixel via iStock]
Follow the Money: Medical Device Firm Orthofix Merges to Form Nearly $700M Revenue Business, Stealthy Men’s Health Startup Looks to Raise $2M, Dallas SPAC Targets $200M IPO, and More
by Kevin Cummings | Oct 17, 2022
In this week’s North Texas deal flow, you’ll also find news about Mavenir’s $155M raise, Pinnacle Realty Advisors raising $5M for ‘brokerage-as-a-service’ platform, Exela Technologies taking its European business unit public, American Airlines’ hydrogen fuel distribution investment, and more.
MORE►
by Kevin Cummings |
Oct 3, 2022
The funding from the National Institutes of Health will help UNT HSC at Fort Worth advance its ongoing research on how Alzheimer's disease affects different racial and ethnic groups. Sid O'Bryant, executive director of UNT HSC's Institute for Translational Research, said there's never been a large-scale study like this before.
“This award and project are nothing short of a bio behavioral ‘moonshot’ program," adds Brian Gladue, HSC executive VP for research and innovation.
MORE►
by Kevin Cummings |
Aug 9, 2022
“Opioids are diabolical, because they actually change the structure and function of your brain; they change the way your reward system works,” said Daniel Powell, CEO at Spark Biomedical.
Meet Powell and six other startup leaders.
Meet Powell and six other startup leaders.
MORE►
by Kevin Cummings |
Jul 25, 2022
Plus, Fort Worth's Harvest Returns raises new fund; new Ryan acquisition makes 2022 its most active M&A year; OpTic Gaming acquires Dallas chatbot startup; Dallas legal education firm boosts digital content library; and Fort Worth's Novaria Group acquires firm with giant aerospace clients.
MORE►
From left, AyuVis Senior Research Scientist Sumita Behera with CEO and Founder Suchi Acharya. [Image: AyuVis]
Fort Worth Immunotherapy Startup Gets $1.8M Grant Ahead of First Clinical Trials
by Kevin Cummings | May 12, 2022
AyuVis, an immunotherapy startup, is set to get a $1.8 million Small Business Innovation Research grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funding will support the pre-clinical research of its drug candidate to treat the second-leading cause of death in premature babies.
Founder Suchismita Acharya calls the timing "perfect."
Founder Suchismita Acharya calls the timing "perfect."
MORE►
by Lance Murray |
May 17, 2019
Also, you'll find out why a researcher at the University of North Texas believes tourism and destination development could help reunite the Korean Peninsula in this roundup of research and development activity in North Texas.
MORE►
by Dave Moore |
Apr 27, 2018
Local startups and researchers can learn how to get federal research-and-tech-driven grant funding and meet federal experts in this conference hosted by the Dallas Regional Chamber.
MORE►
by Lance Murray |
Oct 23, 2017
Nexeon shares are trading over the counter as the company moves forward with advanced medical systems.
MORE►
[Photo illustration by DeoSum via iStock]
Groundbreaking Geneticist Collins to Make SMU Addresses
by Lance Murray | May 16, 2017
Francis S. Collins led the Human Genome Project before taking the reins at the National Institutes of Health.
MORE►
by Rachel Hawkins |
Oct 20, 2016
Rama Ranganathan's team proposes an approach that, for the first time, will let it visualize protein motions with atomic-scale accuracy.
MORE►
by Amanda Hayes |
Aug 9, 2016
A national grant helps a TWU research team to work toward a cure for diseases like Alzheimer's.
MORE►
